94 related articles for article (PubMed ID: 24038948)
1. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
Xu X; Jiang C; Wang S; Tai Y; Wang T; Kang L; Fan Z; Li S; Li L; Fu J; Liu J; Ji Q; Wang X; Wei L; Ye Q
IUBMB Life; 2013 Oct; 65(10):873-82. PubMed ID: 24038948
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
Feng Y; Li L; Zhang X; Zhang Y; Liang Y; Lv J; Fan Z; Guo J; Hong T; Ji B; Ji Q; Mei G; Ding L; Zhang S; Xu X; Ye Q
Cancer Sci; 2015 Oct; 106(10):1313-22. PubMed ID: 26211905
[TBL] [Abstract][Full Text] [Related]
3. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer.
Tu W; Luo M; Wang Z; Yan W; Xia Y; Deng H; He J; Han P; Tian D
Liver Int; 2012 Aug; 32(7):1064-78. PubMed ID: 22583549
[TBL] [Abstract][Full Text] [Related]
6. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
[TBL] [Abstract][Full Text] [Related]
7. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
[TBL] [Abstract][Full Text] [Related]
8. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
[TBL] [Abstract][Full Text] [Related]
9. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
[TBL] [Abstract][Full Text] [Related]
11. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
12. Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.
Santamaria M; Pardo-Saganta A; Alvarez-Asiain L; Di Scala M; Qian C; Prieto J; Avila MA
Gastroenterology; 2013 Apr; 144(4):818-828.e4. PubMed ID: 23295442
[TBL] [Abstract][Full Text] [Related]
13. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.
Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460
[TBL] [Abstract][Full Text] [Related]
14. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
[TBL] [Abstract][Full Text] [Related]
15. 6-[(1-naphthylmethyl)sulfanyl]-9H-purine induces G2/M phase arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Yang XG; Bao YL; Huang YX; Sun LG; Zhang YW; Yu CL; Wu Y; Li YX
Eur J Pharmacol; 2012 Nov; 695(1-3):27-33. PubMed ID: 23000392
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
[TBL] [Abstract][Full Text] [Related]
17. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
18. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
19. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
20. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
